Mylan N V (MYL) Return on Assets ROA from the third quarter of 2020 to third quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mylan N v   (NASDAQ: MYL)


Mylan N V 's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mylan N V 's ROA in the third quarter of 2020?
Mylan N v achieved a return on average assets (ROA) of 0.88 % in its third quarter of 2020, which is below Mylan N V 's average return on assets, which stands at 2.61%.

ROA fell compared to the second quarter of 2020, despite the net income growth of 371.32% from the second quarter of 2020.

However, within the Healthcare sector 171 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2020 quarter, so far to 1969, from total ROA ranking in the second quarter of 2020 at 1985.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Total Assets Change -1.5 % -7.57 % -5.52 % -4.4 % -7.18 %
Y / Y Net Income Change -2.16 % - - -59.96 % 7.41 %
Net Income (TTM) in million 266 271 63 17 48
Return On Assets (TTM) 0.88 % 0.89 % 0.2 % 0.05 % 0.15 %
MYL's Total Ranking # 1969 # 1985 # 2528 # 3089 # 2781
Total Assets (TTM) in million 30,587 29,408 30,146 31,295 31,054
Seq. Total Assets Change 4.01 % -2.45 % -3.67 % 0.78 % -2.4 %
Seq. Net Income Change 371.32 % 89.42 % 1.46 % -89.2 % -

MYL's 5 Years Annual ROA >> Back to MYL Management Effectiveness >> Compare MYL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 51
Sector # 172
Overall # 1925

Return On Assets Statistics
High Average Low
17.1 %
2.61 %
-19.7 %
(Dec. 31. 2006)   (Dec. 31. 2007)





Financial Statements
Mylan N V 's Assets $ 30,587 million MYL's Balance sheet
Mylan N V 's Income $ 186 million Quarterly MYL's Income Statement
MYL's Income by Division See MYL's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change -4.52 % -8.58 % 3.11 % 55.95 % 40.17 %
Total Assets in million 31,256 32,735 35,806 34,726 22,268
Y / Y Net Income Change -95.23 % -49.35 % 45 % -43.38 % -8.79 %
Net Income in million 17 353 696 480 848
Annual Return On Assets 0.05 % 1.08 % 1.94 % 1.38 % 3.81 %

MYL's 5 Years Annual ROA >> Back to MYL Management Effectiveness >> Compare MYL ROA to its Competitors



Comment on MYL's ROA in the fiscal year ending 2019
In the fiscal year 2019 Mylan N V 's ROA decreased compared to previous year to 0.05 %, due to deterioration of net income -95.23 % to $16.80 million, from $352.50 million a year ago, as MYL's assets were $31,255.50 million.


More Return On Assets Ratios
MYL's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MYL's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MYL's Competitors
Subscribers only: Roa for Mylan N V 's Suppliers
Subscribers only: Return On Assets for MYL's Customers

You may also want to know
MYL's Roi MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons
MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector ROA
National Healthcare Corp  2.17 %
The Pennant Group Inc   2.14 %
Gilead Sciences Inc   2.07 %
Insulet Corporation  2.07 %
Progyny Inc   1.92 %
Eagle Pharmaceuticals inc   1.76 %
Integra Lifesciences Holdings Corp  1.66 %
Becton Dickinson And Company  1.64 %
Cantel Medical Corp   1.64 %
Avanos Medical Inc   1.52 %
Acadia Healthcare Company Inc   1.50 %
Tenet Healthcare Corp  1.39 %
Avantor Inc   1.38 %
Amphastar Pharmaceuticals Inc   1.29 %
Mylan N v   0.87 %
Iqvia Holdings Inc   0.85 %
Surmodics Inc   0.70 %
Enovis Corp  0.63 %
Agape Atp Corporation  0.52 %
Brookdale Senior Living Inc   0.48 %
Amneal Pharmaceuticals Inc   0.26 %
National Vision Holdings Inc   0.23 %
Jrsis Health Care Corp  0.21 %

Date modified: 2026-09-26T06:50:51+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.